News stories about ReWalk Robotics (NASDAQ:RWLK) have trended somewhat positive on Tuesday, Accern Sentiment reports. The research group scores the sentiment of media coverage by reviewing more than twenty million blog and news sources in real-time. Accern ranks coverage of public companies on a scale of negative one to one, with scores nearest to one being the most favorable. ReWalk Robotics earned a media sentiment score of 0.16 on Accern’s scale. Accern also gave news stories about the medical device company an impact score of 47.3623609379998 out of 100, indicating that recent media coverage is somewhat unlikely to have an impact on the company’s share price in the near future.

ReWalk Robotics (NASDAQ RWLK) opened at 1.40 on Tuesday. The company has a 50-day moving average price of $1.53 and a 200-day moving average price of $1.70. ReWalk Robotics has a one year low of $1.10 and a one year high of $6.60. The company’s market capitalization is $30.45 million.

ReWalk Robotics (NASDAQ:RWLK) last posted its earnings results on Thursday, August 3rd. The medical device company reported ($0.29) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.35) by $0.06. ReWalk Robotics had a negative net margin of 389.13% and a negative return on equity of 528.26%. The business had revenue of $2.01 million for the quarter, compared to analyst estimates of $1.71 million. During the same period in the prior year, the company posted ($0.64) EPS. The company’s revenue for the quarter was up 145.7% on a year-over-year basis. Analysts expect that ReWalk Robotics will post ($1.30) earnings per share for the current fiscal year.

RWLK has been the subject of several analyst reports. Canaccord Genuity restated a “buy” rating on shares of ReWalk Robotics in a report on Monday, June 12th. Zacks Investment Research raised ReWalk Robotics from a “hold” rating to a “buy” rating and set a $1.50 target price for the company in a research report on Thursday, May 11th. Finally, Oppenheimer Holdings, Inc. set a $4.00 target price on ReWalk Robotics and gave the stock a “buy” rating in a research report on Friday, August 4th. One equities research analyst has rated the stock with a sell rating, one has given a hold rating and three have issued a buy rating to the stock. ReWalk Robotics presently has a consensus rating of “Hold” and a consensus price target of $4.00.

ILLEGAL ACTIVITY WARNING: This piece of content was originally posted by Watch List News and is owned by of Watch List News. If you are accessing this piece of content on another domain, it was illegally copied and republished in violation of U.S. and international trademark & copyright law. The legal version of this piece of content can be viewed at https://www.watchlistnews.com/rewalk-robotics-rwlk-receiving-somewhat-favorable-news-coverage-accern-reports/1488439.html.

In other news, major shareholder Scp Vitalife Partners Ii Lp sold 65,218 shares of the firm’s stock in a transaction that occurred on Tuesday, June 27th. The shares were sold at an average price of $3.05, for a total transaction of $198,914.90. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, Director Wayne Weisman sold 87,000 shares of the firm’s stock in a transaction that occurred on Tuesday, June 27th. The stock was sold at an average price of $3.05, for a total transaction of $265,350.00. The disclosure for this sale can be found here. In the last quarter, insiders sold 199,883 shares of company stock valued at $604,772. 13.70% of the stock is owned by insiders.

ReWalk Robotics Company Profile

ReWalk Robotics Ltd. is a medical device company. The Company is engaged in designing, developing and commercializing exoskeletons that allow individuals with mobility impairments or other medical conditions the ability to stand and walk once again. The Company offers ReWalk, which is an exoskeleton that uses its tilt-sensor technology and an on-board computer and motion sensors to drive motorized legs that power movement.

Insider Buying and Selling by Quarter for ReWalk Robotics (NASDAQ:RWLK)

Receive News & Ratings for ReWalk Robotics Ltd Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ReWalk Robotics Ltd and related companies with Analyst Ratings Network's FREE daily email newsletter.